BackgroundCheck.run
Search For

Christian A Darko, 592815 Cornet Ct, Silver Spring, MD 20904

Known as:
Darko Christian
Related to:
Victoria A Darko 58 Rachel A Darko 28

Christian Darko Phones & Addresses

2815 Cornet Ct, Silver Spring, MD 20904    301-8900231   

8510 16Th St, Silver Spring, MD 20910    301-5629224   

Frederick, MD   

2815 Cornet Ct, Silver Spring, MD 20904    301-5629224   

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: High school graduate or higher
Get Report
Control this profile

Mentions for Christian A Darko

Publications & IP owners

Us Patents

Recombinant Merozoite Protein-1Vaccine

US Patent:
7563883, Jul 21, 2009
Filed:
Aug 14, 2007
Appl. No.:
11/889578
Inventors:
Evelina Angov - Bethesda MD, US
Jeffrey A. Lyon - Silver Spring MD, US
Christian Asare Darko - Silver Spring MD, US
Joe D. Cohen - Brussels, BE
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
C07H 21/04
C12P 21/04
C07K 14/295
A61K 39/015
US Classification:
536 237, 536 231, 435 691, 435 697, 4353201, 4242721, 530350
Abstract:
In this application is described the expression and purification of a recombinant (FVO) MSP-1. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-1is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

Recombinant Merozoite Protein-1Vaccine

US Patent:
8211447, Jul 3, 2012
Filed:
Jul 21, 2009
Appl. No.:
12/507004
Inventors:
Evelina Angov - Bethesda MD, US
Jeffrey A. Lyon - Silver Spring MD, US
Christian Asare Darko - Silver Spring MD, US
Joe D. Cohen - Brussels, BE
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
A61K 39/015
A61K 38/00
US Classification:
4242681, 4241841
Abstract:
In this application is described the expression and purification of a recombinant (FVO) MSP-1. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-1is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

Recombinant P. Falciparum Merozoite Protein-142 Vaccine

US Patent:
2004000, Jan 8, 2004
Filed:
Apr 1, 2003
Appl. No.:
10/404667
Inventors:
Evelina Angov - Bethesda MD, US
Jeffrey Lyon - Silver Spring MD, US
Christian Darko - Silver Spring MD, US
Joe Cohen - Brussels, BE
International Classification:
A61K039/002
C07H021/04
C12P021/02
C12N001/21
C07K014/445
US Classification:
424/191100, 435/069300, 435/252300, 435/252330, 435/320100, 530/350000, 536/023700
Abstract:
In this application is described the expression and purification of a recombinant (FVO) MSP-1. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-1is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

Possible Relatives

Daniel L Darko  Eric Darko  Francis Darko  Gloria K Darko  Irene Darko  Kwame Y Darko  Laszlo L Darko  Christian M Johnson  Christian White  Christian W Jones 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.